Pharmaceuticals 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 13.
BOKS.SKOMMUNIKÉ 2012
· Orderingång 3 122(3 064) Mkr, justerat för förvärvad verksamhet samt
valutaeffekter var orderingången 2% högre än föregående år
· Nettoomsättning 3 085 (3 023) Mkr, justerat för förvärvad verksamhet samt
valutaeffekter har omsättningen ökat med 2 %
· Rörelseresultat 251,5 (317,6) Mkr, en rörelsemarginal på 8,2 (10,5) %
· Resultat efter skatt 159,1 (208,3) Mkr
· Resultat per aktie 12,61 (16,52) kronor
· Utdelning föreslås med 6,50 (6,50) kronor per aktie
Kommentarer av koncernchef
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Brøndbyernes IF Fodbold A/S – Finanskalender 2013
Brøndbyernes IF Fodbold A/S har planlagt følgende datoer for
regnskabsmeddelelser og ordinære generalforsamlinger i 2013 samt primo 2014.
4. marts 2013: Årsrapport 2012 for perioden 1. januar
2012 – 31. december 2012
3. april 2013: Ordinær generalforsamling
23. maj 2013: Delårsrapport for 1. kvartal 2013 (1.
januar 2013 – 31. marts 2013)
30. august 2013: Delårsrapport for 2. kvartal
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
COMMITTEE'S DECISION ON EKSPRESS GRUPP
On February 14, 2013 the Listing and Surveillance Committee of NASDAQ OMX
Tallinn decided to give a warning to AS Ekspress Grupp for violation of NASDAQ
OMX Tallinn rules and regulations chapter Requirements for Issuers (hereinafter
RI) clauses 1.2.1, 7.11.1 and 2.4.1.
Background:
According to RI clause 1.2.1 the Issuer is obliged to secure disclosure of
information stated in RI in such a form and within such time limits as
specified in RI.
According to RI clause 7.11.1 an Issuer sh
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Pohjola Bank plc to redeem Lower Tier 2 subordinated note of EUR 170 million
Pohjola Bank plc
Stock Exchange Release
15 February 2013, 11.35 am
Pohjola Bank plc to redeem Lower Tier 2 subordinated note of EUR 170 million
Pohjola Bank plc (Pohjola) will redeem Lower Tier 2 subordinated note of EUR
170 million, which it issued in March 2008. According to the terms and
conditions, the note was to mature in 25 March 2018 but with the Finnish
Financial Supervisory Authority's permission the issuer has the right to call in
the note early in March 2013.
The note is listed on
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Pohjola Pankki Oyj lunastaa takaisin 170 miljoonan euron Lower Tier 2 -lainan
Pohjola Pankki Oyj
Pörssitiedote
15.2.2013 klo 11.35
Pohjola Pankki Oyj lunastaa takaisin 170 miljoonan euron Lower Tier 2 -lainan
Pohjola Pankki Oyj (Pohjola) lunastaa takaisin 170 miljoonan euron (EUR) alemman
toissijaisen oman pääoman ehtoisen Lower Tier 2 -lainan.
Laina laskettiin liikkeeseen maaliskuussa 2008. Lainan ehtojen mukaisesti laina
erääntyy 25.3.2018, mutta liikkeeseenlaskijalla on oikeus Finanssivalvonnan
luvalla lunastaa laina ennenaikaisesti maaliskuussa 2013.
Laina on note
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Pohjola Bank Abp löser in ett Lower Tier 2-lån på 170 miljoner euro
Pohjola Bank Abp
Börsmeddelande
15.2.2013 kl. 11.35
Pohjola Bank Abp löser in ett Lower Tier 2-lån på 170 miljoner euro
Pohjola Bank Abp (Pohjola) löser in ett Lower Tier 2-lån på 170 miljoner euro
(EUR) som räknas till det undre supplementära kapitalet.
Lånet emitterades i mars 2008. Enligt lånevillkoren förfaller lånet 25.3.2018,
men emittenten har rätt att med tillstånd av Finansinspektionen lösa in lånet i
förtid i mars 2013.
Lånet har noterats på Londonbörsen.
I s.et av december 2012
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
LIQUIDITY PROVIDING IN THE SHARE OF NURMINEN LOGISTICS PLC ENDS
EXCHANGE NOTICE, 15 FEBRUARY 2013 SHARES
The market making in accordance with the LP agreement between Nurminen
Logistics Plc and Evli Bank Plc for the share of Nurminen Logistics Plc will
end on February 18, 2013.
Company name: Nurminen Logistics Plc
Company code: NLG
Trading code: NLG1V
ISIN code: FI0009900187
Orderbook id: 24283
Liquidity Provider (LP): Evli Bank Plc
Liquidity Providing ends: 18 February 2013
NASDAQ OMX HELSINKI
Corporate Client Group
*****************
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Trading by management in Novozymes A/S B Shares
Read the full announcement in PDF format.
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
CENCORP CORPORATION’S FINANCIAL STATEMENT RELEASE 2012
Cencorp Corporation Financial Statement Release 15 February 2013 at 12.00
Finnish time
CENCORP CORPORATION’S FINANCIAL STATEMENT RELEASE 2012
The net sales of Cencorp Corporation’s (“Cencorp”) continuing operations for
the reporting period January – December 2012 was EUR 15.4 million (EUR 21.6
million in 2011). The operating profit of continuing operations was EUR -3.9
million (-4.3), profit for the period EUR -4.8 million (-4.8), earnings per
share were EUR -0.01 (-0.01)
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Kallelse till årsstämma den 20 mars 2013
Aktieägarna i Investment AB Öresund (publ), org.nr. 556063-9147 (”Bolaget”),
kallas till årsstämma onsdagen den 20 mars 2013 klockan 14.00, Citykonferensen
Ingenjörshuset, Malmskillnadsgatan 46 i Stockholm. Kaffe serveras från klockan
13.00.
Anmälan m.m.
Aktieägare som vill deltaga vid årsstämman skall:
· dels vara införd i av Euroclear Sweden AB (”Euroclear”) förd aktiebok
torsdagen den 14 mars 2013;
· dels anmäla sin avsikt att deltaga vid årsstämman senast torsdagen den 14
mars 2013.
An
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Bes. vid extra bolagsstämma i Creades den 15 februari 2013
Extra bolagsstämma i Creades AB (publ) den 15 februari 2013 bes.ade, i
enlighet med förslag från Biovestor Aktiebolag (Sven Hagströmer med familj) och
Pan Capital AB, att Creades ska delas i två bolag genom ett inlösenerbjudande.
Bes.et innebär att Creades aktiekapital ökas med 250.000 kronor genom
fondemission utan utgivande av nya aktier, och därefter minskas med högst
226.468,08 kronor med indragning av högst 7.090.755 aktier i Creades, för
återbetalning till aktieägarna. Inlösenvederlage
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Flaggningsmeddelande i MQ Holding AB
Anmälan om förvärv av eller överlåtelse av aktier eller depåbevis
Emittent 556697-2211 MQ Holding AB
Instrument SE0003303460 AK
Innehavare Nordea Fonder Finland
Före transaktionen
Antal aktier 172 427
Antal rösträtter 172 427
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Cassandra Oil erhåller miljötillstånd i Västerås och inleder provkörning av processanläggningen
Miljö- och konsumentnämnden i Västerås har beviljat Cassandra Oil tillstånd att
bedriva provkörning av däck och plast i Västerås. Idrifttagningen av den första
processanläggningen har därmed övergått i provkörningsfas.
Under provkörningsfasen kommer reglering av processen trimmas in efter de
material som Cassandra Oil använder för att producera olja. Cassandra Oil har
påbörjat tester med blandat plastmaterial och prover på framställd olja kommer
att lämnas in för analys till ett oberoende labor
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Listing of warrants issued by Nordea
NASDAQ OMX Stockholm decides to officially list 152 warrants issued by Nordea
with effect from 2013-02-18. The warrants will be listed on STO Warrants.
Please find instrument identifiers in the attached document.
NASDAQ OMX Stockholm, Issuer Surveillance, dl-ilasto@nasdaqomx.com, +46 8 405
7050
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
Byliner Publishes Phoenix
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
DGAP-DD: HUGO BOSS AG english
Notification concerning transactions by persons performing managerial
responsibilities pursuant to section 15a of the WpHG
Directors' Dealings notification transmitted by DGAP - a company of EquityStory
AG.
The person with duty of notification is solely responsible for the content
of this announcement.
---------------------------------------------------------------------------
Details of the person subject to the disclosure requirement
Last name: Simina
First name: Antonio
Company: HUGO BOSS
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
KALLELSE
till årsstämma i Hufvudstaden AB (publ)
/org nr 556012-8240/
Aktieägarna i Hufvudstaden AB (publ) kallas härmed till årsstämma torsdagen den
21 mars 2013 kl. 16.00 på Grand Hôtel, Vinterträdgården, Stockholm, med entré i
hörnet Stallgatan/Blasieholmsgatan. Entrén öppnas kl. 15.00.
Kallelse och samtliga tillgängliga handlingar finns på bolagets hemsida
www.hufvudstaden.se.
Bilaga
Kallelse årsstämma 2013
Informationen är sådan som Hufvudstaden AB (publ) är skyldig att offentliggöra
enligt la
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
NASDAQ OMX Global Data Products Nordic Newsletter #5 - 2013
Dear Customer,
Please find attached the Nordic Newsletter from NASDAQ OMX Global Data Products.
Website: http://nordic.nasdaqomxtrader.com/marketdata/
For further information please contact: DataProducts@nasdaqomx.com
Source: Medical News (via PRIMEZONE) - February 15, 2013 Category: Pharmaceuticals Source Type: news
The Global Over-The-Counter (OTC) Pharmaceutical Market To Grow At A...
Research and Markets Announces the Publication of the Research Report - Global Over-the-counter Pharmaceuticals Market 2012-2016(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10433860.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Generics in Global Antivirals Market Forecast to Reach $9.2 Billion by...
Research and Markets Announces the Addition of GBI's Research "Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10433563.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Model N Files Registration Statement for Initial Public Offering
(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10431637.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Chemir Announces New Custom Synthesis Laboratory
New chemical synthesis laboratory expands Chemir's capabilities and service offerings.(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/Synthesis/Laboratory/prweb10431173.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Develops...
Diet Doc recently teamed up with iPhone apps maker Appolicious to develop their best apps ever.(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/hcg-shots/hcg-drops/prweb10431121.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Toxicology Education On The Go - One Year of the Journal Of Medical...
The Journal of Medical Toxicology, the official print journal of the American College of Medical Toxicology, celebrates its first year of delivering scientific journal content in a humorous and...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10430578.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Natural Herpes Cure Resolve Herpes Launches Improved Version that is...
The new formula is available in a two-step, 50-day detox program(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10427687.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
HealthEconomics.Com Announces Newsletter Promoting Health Outcomes and...
Launch of Jobs Newsletter Focuses on Jobs in Health Outcomes Research, Pharma Pricing and Reimbursement, and Health Economics(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/jobsnewsletter/prweb10426534.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Infinata’s BioPharm Insight Signs 200th Media Partner, Inaugurates...
Biopharmaceutical industry organizations sign up to raise visibility and attendance at key events(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10426296.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
New Bipolar Depression Online CME Activity Launches March 2013
CME Outfitters’ Accepting Registration For Its Upcoming neuroscienceCME Live and On Demand Activity with Interactive Q&A Focusing on Bipolar Depression(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10425536.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Wohl Associates Features New Used Tablet Packaging Equipment Including...
Wohl Associates has introduced new pre-owned tablet presses. Their tablet packaging equipment offers a wide selection to choose from.(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/tablet-packaging-equipmen/wohl-associates/prweb10424703.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
PBM Experts to Discuss Non-Rate Contracting Terms in Feb. 25 Atlantic...
Get recommendations from a pharmacy benefit consultant and pharmacy benefit attorney on securing a positive, effective relationship through the contract terms between PBMs and plan sponsors in the...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10420841.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
d’Oliveira & Associates Issues Webpage With Current Information On...
d’Oliveira & Associates Issues Press Release with Current Information on Mirena IUD Lawsuits(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10395944.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Nevada Pain Network Goes Live With Online Pain Management Textbook
The Nevada Pain Network, which is part of the US Pain Network, has launched an online pain management textbook. The website contains hundreds of pages of current pain management education, which is...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/painmanagementlasvegas/painclinichenderson/prweb10393172.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Da Vinci Robotic Surgery Lawsuits Being Investigated by Bernstein...
The Firm is investigating da Vinci robot lawsuits on behalf of individuals who suffered organ and blood vessel perforation, surgical burns or infections, and other serious injuries allegedly due to...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/da-vinci-robot-lawsuit/da-vinci-complications/prweb10433372.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
MOCON Unveils WVTR Instrument for Ultra-high Barrier Films with...
MOCON, Inc. (NASDAQ: MOCO), the world’s leading manufacturer of package integrity instrumentation, is launching a new system to measure the water vapor transmission rate (WVTR) of ultra-high barrier...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10433299.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
DePuy ASR Hip Lawsuit Update: Bernstein Liebhard LLP Comments on Hip...
The Firm is actively filing DePuy ASR lawsuits on behalf of individuals affected by the 2010 metal-on-metal hip implant recall.(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/depuy-asr-hip-lawsuit/depuy-asr-hip-recall/prweb10433282.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Empathica Consumer Insights Panel Cites One-Third of U.S. Consumers...
Consumers remain optimistic in spite of continued financial difficulties, citing lingering concerns around economy and debt(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10431453.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
RURO Updates FreezerPro® to Version 6
RURO is pleased to announce the release of the 6th major version of the FreezerPro® platform. New version adds functionality and improvements.(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10429642.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
New Lawsuit on Avodart High-Grade Prostate Cancer: Now, AttorneyOne...
According to court documents, on February 4th, 2013, a woman filed a lawsuit in Jefferson County District Court alleging her husband developed high-grade prostate cancer from Avodart and died. In...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10427605.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Lean Six Sigma World Conference
KnowWare International Inc. announces that Jay Arthur has been selected to be an Opening Keynote Speaker at the 2013 Lean Six Sigma World Conference. The conference is sponsored by ISO 9000/QMS and...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10425427.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
InfoDesk Introduces Newsletter Archive iWidget
New iWidget helps organizations archive and manage internal newsletters in the cloud(PRWeb February 15, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10435662.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Stemedica Forms Cardiology Division. Sergey Sikora, PhD Appointed As...
Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research, development, and clinical applications announced today that it has formed a Cardiology Division to...(PRWeb February 15, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10435703.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Laura Rosenfield, M.D., Receives InTone Specialist Certification To...
InControl Medical has certified Laura Rosenfield, M.D., to prescribe InTone for women with bladder leakage.(PRWeb February 15, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10433075.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Drug Makers Get EU Complaint over Generic Fentanyl Delay: Now,...
As Bloomberg reported on January 31st, 2013, Johnson & Johnson and Novartis were sent antitrust objections by European Union regulators over generic Fentanyl delay. In light of these news,...(PRWeb February 15, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10432766.htm
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
Chesapeake Innovation Center looks to add health IT tenants
Chesapeake Innovation Center, an Annapolis business incubator, has added a health information technology track.
The incubator primarily works with intelligence, security and cyber startup companies. Administrators wanted to include health IT because it is a growing industry and because some cyber security companies are expanding their businesses to work in the health care industry, said Renée Winsky, the incubator’s executive director.
“We want to be supportive of this industry sector,”…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 15, 2013 Category: Pharmaceuticals Authors: Sarah Gantz Source Type: research
02.19.13 -- 7 Keys To Establishing A Quality Culture Your Senior Management Will Love
02/19/13 Pharmaceutical Online Newsletter
Source: Pharmaceutical Online News - February 15, 2013 Category: Pharmaceuticals Source Type: news
Mylan in talks to buy Arcolab’s injectables unit
Strides Arcolab and Mylan are in exclusive talks for the deal on Strides’ injectables unit, Agila Specialties, in a deal close to $2 billion
Source: The Economic Times Healthcare and Biotech News - February 15, 2013 Category: Pharmaceuticals Source Type: news
Feature Story: Reporting on Our Progress
273 million lives impacted. $8.5 billion research and development expense. 210,500 hours volunteered. $1.3 billion donated. The 2011 Corporate Responsibility Report details our progress.
Source: Merck.com - Feature Stories About Merck - February 15, 2013 Category: Pharmaceuticals Source Type: news
Feature Story: Staying the Course Against Infectious Disease
Source: Merck.com - Feature Stories About Merck - February 15, 2013 Category: Pharmaceuticals Source Type: news
On, Wisconsin: Scott Walker's Rejection of Obamacare's Medicaid Expansion is a Model for the Nation
All over the country, state governors and legislatures have been wrestling with the decision of whether or not to sign up for Obamacare’s significant expansion of Medicaid, America’s government-run health insurance program for the poor. Prominent Republican governors, like John Kasich in Ohio, have said yes to Medicaid, reasoning that if Ohio doesn’t grab the federal money, other states will. But, as Wisconsin governor Scott Walker now shows, there is a far better path forward, one that reduces the footprint of Medicaid while providing coverage to the uninsured.
Source: Forbes.com Healthcare News - February 15, 2013 Category: Pharmaceuticals Authors: Avik Roy Source Type: news
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEtablet, Film Coated [Aurobindo Pharma Limited]
Updated Date: Feb 15, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 15, 2013 Category: Drugs & Pharmacology Source Type: news
